rGel/BlyS (Children's Hospital Los Angeles)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NamerGel/BlyS (Children's Hospital Los Angeles)
Drug Alias Nametoxin-BAFF fusion protein (Children's Hospital Los Angeles)recombinant Gelonin/B-lymphocyte stimulator (Children's Hospital Los Angeles)
ClassificationBiologics > Protein drugs > ToxinBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionB-cell-activating factor/B lymphocyte stimulator ligand
TargetsB-cell-activating factor/B lymphocyte stimulator
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChildren'S Hospital Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChildren'S Hospital Los AngelesThe University Of Texas MD Anderson Cancer Center
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A